Fabrication of epidermal growth factor (EGF)- and vancomycin-loaded chitosan nanoparticles to enhance wound healing

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Elmotazbellah M.; Soliman S.M.A.; El-Ghany M.N.A.; Shemis M.A.; Elzayat E.M.; Hassan N.

Journal: Naunyn-Schmiedeberg's Archives of Pharmacology

Publisher: Springer Science and Business Media Deutschland GmbH

Publication Date: 25 October 2025

Volume / Issue: Volume 399 / Issue 4

Pages: 4973–4985

ISSN: 281298

DOI: 10.1007/s00210-025-04616-8

Scopus: View on Scopus

PubMed: 41137869

Document Type: Article

Access: All Open Access; Green Open Access; Hybrid Gold Open Access

Authors and Affiliations

Elmotazbellah M., Biotechnology Department, Faculty of Science, Cairo University, Giza, Egypt; Soliman S.M.A., Chemistry Department, Faculty of Science, Cairo University, Giza, Egypt; El-Ghany M.N.A., Botany and Microbiology Department, Faculty of Science, Cairo University, Giza, Egypt; Shemis M.A., Biochemistry and Molecular Biology Department, Nanobiotechnology Unit, Theodor Bilharz Research Institute, Giza, Egypt; Elzayat E.M., Biotechnology Department, Faculty of Science, Cairo University, Giza, Egypt, Biochemistry and Molecular Biology Department, Nanobiotechnology Unit, Theodor Bilharz Research Institute, Giza, Egypt; Hassan N., Biotechnology Department, Faculty of Science, Cairo University, Giza, Egypt, Biochemistry and Molecular Biology Department, Nanobiotechnology Unit, Theodor Bilharz Research Institute, Giza, Egypt

Abstract

Delayed and impaired wound healing is a persistent issue, these wounds are prone to infections and suffer from poor cell re-epithelization. Nanoparticles can be utilized to aid in the wound healing process, they are able to carry and deliver biomolecules and drugs into wounds. Due to their small sizes, they can deeply penetrate tissues. This study reports the development of a dual-delivery system of chitosan nanoparticles (CSNPs) co-encapsulating epidermal growth factor (EGF) and vancomycin (VCM) for potential application in wound healing. The nanoparticles were fabricated using the ionotropic gelation method with tripolyphosphate anions (TPP) and characterized for their physicochemical properties including the size, shape, polydispersity index, and zeta potential of the nanoparticles. High-performance liquid chromatography (HPLC) was utilized to measure the encapsulation efficiency of the nanoparticles and to evaluate the release kinetics. The dual-loaded CSNPs exhibited a mean particle size of 458.39 nm and a high positive zeta potential. The encapsulation efficiency and in vitro release kinetics were quantified by HPLC. The formulation demonstrated a sustained release profile for both EGF and VCM. The nanoparticles showed no significant cytotoxicity against human dermal fibroblasts (HDFs) at concentrations up to 4 mg/ml and exhibited a minimum inhibitory concentration (MIC) of 2 mg/ml against Staphylococcus aureus. Furthermore, the dual-loaded nanoparticles significantly enhanced cell migration in an in vitro scratch assay, indicating their potential to accelerate wound closure. This work highlights the promise of dual-loaded chitosan nanoparticles as a novel therapeutic strategy to simultaneously promote tissue regeneration and combat bacterial infections in wounds. © The Author(s) 2025.

Keywords

Chitosan; Epidermal growth factor; Nanoparticles; Vancomycin; Wound healing; Anti-Bacterial Agents; Cell Survival; Drug Carriers; Drug Liberation; Fibroblasts; Humans; Particle Size; Staphylococcus aureus; antiinfective agent; drug carrier; nanoparticle; chemistry; drug effect; drug release; fibroblast; human

Citation Information

Scopus Citations: 4

For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit